Prohibition Partners

Prohibition Partners · Free weekly briefing

International Cannabis Weekly

The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.

440

6 regions31 stories17 publishers12 countries

← №439All issues441

Top story

Germany's post-CanG import surge loses steam as Q4 growth stalls

Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year. The latest medical cannabis import figures from BfArM, covering the final quarter of 2025, show that the post-CanG boom may finally be slowing after consecutive periods of high double-digit growth.

Business of CannabisDEMedical

  1. 01

    Ananda Pharma cleared to begin dosing in NHS-backed CBD endometriosis trial

    Business of CannabisGBMedical

  2. 02

    Tilray buys UK craft brewer BrewDog in cut-price £33M deal

    dailymail.co.ukGBBusiness & Investment

Europe

5 stories
  • Evidena Care launches Switzerland's first integrated medical cannabis comparison platform

    CHBusiness & Investmentlink no longer available

  • Malta authorises cannabis social clubs to hold up to 3.5 kilograms

    MTAdult-uselink no longer available

  • Organigram's acquisition of Sanity Group signals Big Tobacco bet on European cannabis

    EUBusiness & Investmentlink no longer available

  • North America's biggest players expand footprints in 'scramble for Europe'

    Business of CannabisEUBusiness & Investment

  • UK MP calls for government-funded trials in Hannah Deacon campaign

    GBMedicallink no longer available

Oceania

5 stories

Never miss an issue

International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.

From the research library

Global Medical Cannabis Market Review

14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.

From £1,265

View report